Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
The CEO of a certain trading platform founded the company NewLimit, which has secured $45 million in funding to start clinical research on longevity.
[Chain News] PANews, October 21, reported that NewLimit, a longevity research company co-founded by the CEO of a trading platform, shared news from its co-founder Jacob Kimmel stating that NewLimit has secured an additional $45 million in financing. Investors include Lilly Ventures, Duke University, S32, Abstract, among others, with participation from new and old shareholders such as Kleiner Perkins, Dimension, Human Capital, and Boost VC. This round of funding is aimed at the technological breakthroughs in its project to restore youthful liver function, with plans to initiate clinical research in the coming years.